Works matching IS 11732563 AND DT 2021 AND VI 41 AND IP 11


Results: 8
    1
    2
    3
    4

    First-in-Human, Single-Ascending Dose and Food Effect Studies to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Cetagliptin, a Dipeptidyl Peptidase-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus.

    Published in:
    Clinical Drug Investigation, 2021, v. 41, n. 11, p. 999, doi. 10.1007/s40261-021-01088-5
    By:
    • Wang, Lu;
    • Lu, Jinmiao;
    • Zhou, Sufeng;
    • Zhao, Yuqing;
    • Xie, Lijun;
    • Zhou, Chen;
    • Chen, Juan;
    • Ding, Sijia;
    • Xie, Daosheng;
    • Ding, Juping;
    • Yu, Qiang;
    • Shen, Hong;
    • Hao, Guangtao;
    • Shao, Feng
    Publication type:
    Article
    5
    6
    7
    8